Zynerba Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Zynerba Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2022.
  • Zynerba Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was $360K.
  • Zynerba Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was $1.2M.
  • Zynerba Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $216K.
  • Zynerba Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$539K, a 174% decline from 2020.
  • Zynerba Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was $726K, a 47.3% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $216K +$754K Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 -$539K -$1.26M -174% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $726K -$651K -47.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 $1.38M +$890K +183% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $487K -$324K -40% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 $811K +$1.02M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 -$208K -$216K -2935% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-11
2015 $7.35K +$9.2K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$1.84K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.